You are here: Geisinger Medical
Laboratories > Test
Catalog
Geisinger Medical Laboratories Test Catalog
FECAL OCCULT BLOOD, EIA |
||
ORDERING INFORMATION: |
Geisinger Epic Procedure Code: LAB2269 Geisinger Epic ID: 29481 | |
SPECIMEN COLLECTION |
||
Specimen type: |
Random stool | |
Preferred collection container: |
||
Specimen required: |
Inpatient / ED: Non-sterile specimen container Off-site specimen: FOBT Collection Vial |
|
Special notes: |
Offsite specimens: Do not overfill collection vial. All fields (Collection Date, Name, MRN, or DOB if MRN is not available) in the label must be filled out. Patient Instructions Inpatient / ED: Testing limited to pediatric patients only. Collect feces in a clean leak-proof container. Do not add fixative or preservative. |
|
Patient preparation: |
Patients with hemorrhoids or menstrual bleeding should wait until bleeding ceases. | |
| SPECIMEN PROCESSING |
||
Transport temperature: |
Room temperature (preferred) or refrigerated. | |
Specimen stability: |
Collection vial: Room temperature: 6 days. Refrigerated: 30 days. Non-sterile containers: 24 hours. |
|
Rejection criteria: |
Overfilled specimens: samples that are not liquid enough to place drops on the cartridge. Specimen that does not have fecal matter added to the collection vial and the liquid in the vial is clear. Specimen past the stability limits. | |
TEST DETAILS |
||
Reference interval: |
Negative. | |
Interpretation guide: |
Positive test indicates the presence of human hemoglobin (blood) in stool. May be upper GI or lower GI. | |
CPT code(s): |
82274 | |
| Note: The billing party has sole responsibility for CPT coding. Any questions regarding coding should be directed to the payer being billed. The CPT codes provided by GML are based on AMA guidelines and are for informational purposes only. | ||
Test includes: |
Immunoassay for human hemoglobin. | |
Methodology: |
Immunoassay |
|
Synonyms: |
Hemosure iFOBT Fecal Occult Blood Test Occult blood test FIT, iFOBT, FOBT Immunological FOBT Occult Blood Screen (EIA Mail in)
|
|
Clinical significance: |
This test detects the presence of human hemoglobin in stool that may be of gastrointestinal or colorectal origin. It is used as a screen to detect polyps and lesions before they become cancerous. | |
Doctoral Director(s:) |
Hoi-Ying Elsie Yu, PhD, DABCC Sheng-Ying (Margaret) Lo, PhD, DABCC |
|
| Review Date: | 12/14/2022 | |
Performing Locations
Geisinger Wyoming Valley Medical Center
Geisinger Shamokin Area Community Hospital
Geisinger Community Medical Center
Geisinger Medical Center Muncy